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INTRODUCTION
The essential function of the innate immune system stems
from its ability to provide a rapid response, acting directly
on the pathogen without the need for induction or matura-
tion. The role of Toll signaling in innate immunity in flies
was initially studied in the setting of antifungal responses
to the pathogen Aspergillus fumigatus (1). Toll-like receptors
(TLRs), with the exception of TLR9 which exists in the cyto-
plasm, are all transmembrane molecules. The extracellular
amino termini have variable leucine-rich repeat domains,
which are involved in the recognition of pathogen-associat-
ed molecular patterns (PAMPs): TLR2 for peptidoglycans
(2, 3), lipoteichoic acid (2), lipoarabinomannan (3), and bac-
terial lipoproteins (4); double-stranded RNA by TLR3; TLR4
for lipopolysaccharide (LPS) (5), and heat-shock protein (hsp);
TLR5 for flagellin (6); TLR9 for bacterial DNA (7), and the
intracellular domains contain a conserved Toll/interleukin-1
(IL-1) receptor (TIR) domain (8). To date, a total of 10 human
TLRs have been identified (9), and TLR11 is being studied
in mice and protozoa (9, 10).
Arbour et al. demonstrated 2 cosegregating missense muta-
tions in the extracellular domain of the receptor of the human
TLR4 (hTLR4) gene, an aspartic acid-to-glycine substitution
at position 299 of the amino acid sequence (Asp299Gly) and
a threonine-to-isoleucine substitution at position 399 of the
amino acid sequence (Thr399Ile). These mutations are known
to be associated with hyporesponsiveness to LPS and an in-
creased incidence of Gram-negative septic shock, which was
initially demonstrated by the observation that LPS-hypore-
sponsive C3H/HeJ mice have a point mutation in the TLR4
gene (11, 12). TLR2 is found in substantial amounts on mono-
cytes and neutrophils, but also on dendritic cells. Studies em-
ploying TLR2 knock out mice revealed a higher susceptibil-
ity to infections caused by Gram-positive bacteria, spirochetes,
and mycobacteria (13-15).
We focused on TLR4 (Asp299Gly, Thr399Ile) and TLR2
(Arg753Gln, Arg677Trp) mutations, because they have been
the most extensively studied and are known to play promi-
nent roles in response to Gram-negative and Gram-positive
infections (16). The purpose of this study is to describe the
prevalence of these genetic variations in the bacteremia pati-
ents and in healthy volunteers in Korea. 
MATERIALS AND METHODS
A total of 154 patients with bacteremia and 179 healthy
volunteers at Yongdong Severance Hospital were recruited
between March 2003 and September 2004. Patients who
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Toll-like receptors (TLRs) are pattern-recognition receptors that are important in in-
nate immune responses to bacterial infection. The purpose of this study is to describe
the prevalence of TLRs genetic variations in the bacteremic patients in Korea. A
total of 154 patients with bacteremia and 179 healthy volunteers were included. The
Asp299Gly and Thr399Ile allele of the TLR4 gene and Arg753Gln and Arg677Trp
allele of the TLR2 gene were tested by PCR-RFLP. The DNA sequences were deter-
mined to confirm the PCR-RFLP results. Contrary to the expectation, no genetic
polymorphisms were detected in both groups of this study, suggesting that it is very
rare in Korean. 
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had at least one positive blood culture and took antibiotics
for treatment were included in this study. The informed con-
sent was received from all patients and volunteers.
Whole blood was collected from the study subjects, and
genomic DNA was extracted using the QIAamp DNA Blood
Mini Kit (Qiagen, Hilden, Germany), according to the man-
ufacturer’s protocol, including RNase-free DNase digestion
(17). PCR primers were designed to allow a distinction of
wild-type and mutant TLR4 alleles based on the presence of
restriction enzyme recognition sites (17). In both cases, the
forward primer sequences were altered to generate a restric-
tion site in the mutant allele. For TLR2, we designed primers
spanning a region of 340 bp including both polymorphisms
(Arg753Gln, Arg677Trp) (27) (Table 1). Reactions were set
up using the AmpliTaq� PCR kit (Applied Biosystems, Fos-
ter City, CA, U.S.A.). In a total reaction volume of 50 L, 5
L 10×PCR buffer, 20 pM each primer, 0.1 g genomic
DNA, 2.5 U Taq DNA polymerase, 200 M dNTP mixture,
and 1.5 mM magnesium chloride were combined. Reactions
were run on a GeneAmp PCR System 2400 (Applied Bio-
systems) using the following conditions: 94℃ for 5 min, then
30 cycles of 94℃ for 30 sec, 55℃ (58℃ for TLR2) for 30
sec, and 72℃ for 30 sec. QIAquick Gel Extaraction Kit (Qia-
gen, Hilden, Germany) was used for extracting and purifying
amplicons after PCR. Five microliters of the resulting prod-
ucts were used for an overnight digest with the appropriate
restriction enzyme (Table 1) in a total volume of 20 L at
37℃, and digests were run out on a 4% MetaPhore� agarose
gel (BMA, Rockland, ME, U.S.A.) to determine the TLR2
and TLR4 alleles. To confirm the mutant TLR2 and 4 alle-
les, the DNA sequences were determined with ABI Prism�
3100 Genetic Analyzer (Applied Biosystems, CA, U.S.A.)
in all PCR products
RESULTS
The mean age of the bacteremia patients was 58.7±17.2
yr, and the sex ratio was 84 men to 70 women. The mean age
of the volunteers was 47.0±14.0 yr, and the sex ratio was
102 men to 77 women. Specific organisms were identified
in bacteremia patients.
Primary sites of bacteremia in patient group were as fol-
lows: urine 31 (20.1%), wound 18 (11.7%), lung 9 (5.8%),
catheter 7 (4.5%), abscess 5 (3.3%), bile 3 (1.9%), peritoneal
fluid 2 (1.9%), throat 2 (1.9%), others 5 (3.3%), and unknown
sites 72 (46.8%). In the bacteremia patients, there were 79
(51.3%) Gram-positive infections, 65 (42.2%) Gram-nega-
tive infections, 2 (1.3%) anaerobic infections and 8 (5.2%)
fungal infections. Staphylococcal infections were 60 (75.9%)
out of 79 Gram-positive infections. Compared to the positive
control of PCR-RFLP pattern of Asp299Gly (223 bp), which
has a restriction site by NcoI, the band from all specimens of
this study appeared on 249 bp which represents for a wild
type. So there were no Asp299Gly polymorphisms in any of
the specimens. If another TLR4 polymorphism, Thr399Ile,
was present, it should be restricted by HinfI and the band
should be noted on 378 bp. However, the band appeared on
410 bp which represents for a wild type, too. 
As for the TLR2 wild type, there are two restriction sites
by AciI. From these restriction sites, three bands appear on
38 bp, 75 bp, and 227 bp in wild type. If TLR2 polymor-
Primer Sequences Rsestriction enzymes
TLR2  Forward; 5′-GCCTACTGGGTGGAGAACCT-3′ AciI
Arg753Gln Reverse; 5′-GGCCACTCCAGGTAGGTCTT-3′
Arg677Trp
TLR4  Forward; 5′-GATTAGCATACTTAGACTACTACCTCCATG-3′ NcoI 
Asp299Gly Reverse; 5′-GATCAACTTCTGAAAAAGCATTCCCAC-3′
TLR4 Forward; 5′-GGTTGCTGTTCTCAAAGTGATTTTGGGAGAA-3′ HinfI 
Thr399Ile Reverse; 5′-ACCTGAAGACTGGAGAGTGAGTTAAATGCT-3′
Table 1. Oligonucleotide primer sequences and restriction enzymes for genotyping the TLR2 and TLR4 polymorphisms
The underlined bases in both forward primers indicate the nucleotide altered to create a NcoI (TLR4 Asp299Gly) and HinfI (TLR4 Thr399Ile) restriction
site, respectively (17, 27).
410 bp
2,642 
bp
500 bp
227 bp
75 bp
38 bp
249 bp
223 bp
100 bp
26 bp
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Fig. 1. Representative results of samples tested for TLR 2 and 4
polymorphisms with the PCR-RFLP. 
M: DNA 100 bp ladder size marker; 1: TLR4 (Arg299Gly) positive
control (223 bp); 2-3: TLR4 (299) in bacteremia (249 bp); 4-5: TLR4
(299) in healthy control (249 bp); 6-7: TLR4 (399) in bacteremia
(410 bp); 8-9: TLR4 (399) in healthy control (410 bp); 10-11: TLR2
in bacteremia (3 bands: 38 bp, 75 bp, 227 bp); 12-13: TLR2 in
healthy control (3 bands: 38 bp, 75 bp, 227 bp); : DNA 50 bp
ladder size marker.
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phisms (Arg753Gln or Arg677Trp) are present, there is only
one restriction site and therefore, only two bands (75 bp, 265
bp in Arg753Gln and 38 bp, 302 bp in Arg677Trp) should
be appeared. In our results, however, three bands appeared in
all the patients and healthy volunteers, which represented for
wild type (Fig. 1). To verify these negative findings, we per-
formed sequencing analysis on all samples, and we confirmed
that there were no polymorphisms in this study subjects. 
DISCUSSION
Susceptibility to lethal infections throughout a person’s life-
time may be significantly dependent on genetic factors such
as genetic polymorphisms (16, 18). The role of a TLR4 poly-
morphism on the susceptibility to infections is still contro-
versial and it is currently unresolved whether a hyporespon-
sive LPS signaling pathway is beneficial or detrimental to the
host (11, 19-21). 
The frequency of the Asp299Gly allele of the TLR4 gene
has been reporting as variable range (3-18%) according to
the study subjects (19-24). However, Okayama et al. report-
ed that the Asp299Gly allele was not detected in any of the
specimens, suggesting that it is very rare in Japanese popu-
lation (25). Arg753Gln mutation has been found in 2.7%
in whites by Lorenz et al. (26), while higher mutation ratio
(14.6%) was reported in German (27). While no individu-
als carrying the Arg677Trp SNP (single nucleotide polymor-
phism) were identified in a large group of whites (27), it was
found in 10 of 45 lepromatous leprosy patients (22%) (28).
Kang et al. reported high frequency (22%) of TLR2 muta-
tion in Korean lepromatous leprosy patients (28), but no mu-
tations were identified in controls and tuberculoid leprosy
patients. However, our data showed that no polymorphisms
were present in bacteremia patients, which is contradictory
to the previous studies. It could not be compared directly to
the Kang’s study (28) because no leprosy patients were includ-
ed in our study. But the results that there was no mutation
in healthy control groups in both studies are similar. Consid-
ering variable results as described above, it may suggest that
the genetic polymorphisms vary according to the race, organ-
isms, or other certain conditions. Also the genetic polymor-
phisms may not be functional or TLR function is not rate
limiting step in certain organisms or conditions (11, 29). Or
other member of the TLR family or their cofactors contribute
to effective innate immunity in Korean, even if TLR2 or 4
function or expression is impaired. Compare to the results
by Lorenz et al. (26), no Arg753Gln polymorphism was found
among 60 staphylococcal infections in this study. This lack
of correlation may be due to the rarity of this polymorphism
in Koreans or additional genes like TNF- may be involved
in determining the susceptibility to septic shock for Gram-
positive organisms (30).
The limitations of our study are as follows. First, we could
get only one positive control sample for Asp299Gly and not
for others. So we did the sequencing analyses for these loci
to confirm our PCR results. Second, we did not examine the
full sequence of TLR2 and TLR4, but we only sequenced for
the specific gene loci that polymorphism is known to be oc-
curred most frequently. The possibility cannot be ruled out
that as-yet-unidentified other polymorphic loci which can
influence susceptibility to Gram-negative or -positive infec-
tion may be present within TLR4 or 2. Third, our sample
size is relatively small, so further increase of sample size of
the cohort will be needed. 
In spite of these limitations, this report is important as the
first research about frequency and correlation of TLR2 and
TLR4 polymorphisms to bacteremia in an Asian country.
Though our results were negative, additional polymorphisms
might be associated with molecular pathogenesis of sepsis.
If the sepsis-specific genetic polymorphisms are found from
further studies, it will be possible to provide individualized
preventive and therapeutic measures for this devastating dis-
ease in the future. However, larger sized studies are needed. 
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